Company intelligence / Profile preview

ApothecaryRx

Oklahoma City, Oklahoma, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

ApothecaryRx is a wellness and healthcare company specializing in the development and distribution of hemp-derived cannabinoid products. The company offers a diverse portfolio of formulations, including CBD, Delta-8, and Delta-9 THC, designed to address common health concerns such as chronic pain, anxiety, and sleep disturbances. ApothecaryRx emphasizes product quality through rigorous third-party laboratory testing and provides its products through both direct-to-consumer and wholesale channels. Their delivery formats include tinctures, edibles, topicals, and softgels, with a focus on minor cannabinoids like CBG and CBN for targeted therapeutic effects.

Therapeutic areas: PsychiatryImmunologyNeurology
Modalities: Small molecule
Industry: Food & Nutrition

Beyond the preview

Go deeper on ApothecaryRx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ApothecaryRx.

Explore the full profile